A Quarter of Patients Develop Recurrent Hypertropia After SES Surgery
A retrospective single-center case series of 128 patients examined long-term outcomes of strabismus surgery for hypertropia caused by sagging eye syndrome (SES). The study reported that although surgery significantly reduced hypertropia immediately postoperatively, at final follow-up (mean about two years later) 31% of patients had symptomatic hypertropia, including 25% with recurrence of the original hypertropia and 6% due to overcorrection; recurrences accrued gradually over time without an early plateau and were not associated with demographic or clinical factors or surgical technique. The authors state this pattern is consistent with the progressive degenerative pathophysiology of SES.
Most relevant for: Older adults undergoing strabismus surgery for hypertropia related to sagging eye syndrome.
Read the original at American Journal of OphthalmologySummary written by an AI model from the source text and dated by the source's publication date. Check the original before acting on it. How MedFollow selects and summarizes updates.
Informational only. Not medical advice. Not a substitute for clinical judgment. Always consult current guidelines and your own clinical judgment.
Specialties
More ophthalmology updates
- Multisociety task force disputes need for routine high-level disinfectionOct 9, 2026
- Donor Diabetes Severity Not Linked to DMEK Graft OutcomesOct 8, 2026
- AAO review finds injection and sponge MMC comparably effective in trabeculectomyOct 7, 2026
- Home tonometry metrics linked to visual field loss in glaucomaSep 30, 2026
- Meta-analysis confirms teprotumumab benefits and side effects in thyroid eye diseaseSep 29, 2026